AFP Testing Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Alpha-fetoprotein
(AFP) is the most widely found plasma protein in human fetus. The AFP
protein found in humans is encoded by the AFP gene that is located on
chromosome 4. It is a major plasma protein which is produced during fetal
development in yolk sac and the liver. AFP is a glycoprotein which is
found in monomeric, dimeric and trimeric forms. The protein is normally made by
immature liver cells in the fetus therefore; infants have higher levels of AFP,
which falls to normal adult level by the end of first year.
To check out the complete table of
contents, visit:
http://www.marketresearchreports.biz/analysis-details/afp-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Usually,
low level of AFP protein is found in pregnant women’s and in the blood of
healthy adults. However, biochemical tests are performed to check the level of
AFP protein in pregnant women’s blood. The high or low level of AFP helps
doctor to estimate the chances of birth defect or other problems. These AFP based
screening test helps to determine certain chromosomal aberrations such as
Down’s syndrome or Edwards’s syndrome, neural tube defects and certain types of
cancer.
AFP
screening tests are being used widely and many of them are commercially
available due to their sensitivity in cancer diagnosis. Usually, level of AFP
in human blood is below 10ng/ml but it elevates up to 500ng/ml in patients
suffering from chronic hepatitis. In addition, high level of AFP is also
witnessed in patients suffering lymphoma, Hodgkin’s disease, brain tumors and
renal cancer. Cancer diagnostic segment is growing exponentially as the
researchers are discovering new techniques and specific antigens to further
enhance the treatment mode. Therefore, AFP testing market is expected to grow
with rise in cancer incidences. Similarly, growth in AFP testing market is also
poised to grow with rise in geriatric population, which is more susceptible to
diseases and tumor development.
Some
of the market players in this industry are Abbott Laboratories, Biomedical
Diagnostics, Bio-Rad Laboratories, Beckman Coulter, Kreatech Diagnostics, Roche
Diagnostics and other significant players.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This
report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/175729
Reasons
for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Latest Reports:
Central
Nervous System (CNS) Biomarkers Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/central-nervous-system-cns-biomarkers-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Biomarkers
are used to indicate the biological state of a process, pathogenic process or
therapeutic action. Biomarkers facilitate understanding the development
of a chronic disease, relationship between exposure to environmental chemicals
and identification of subgroups of people who are relatively at high risk of
developing disease. Continued development in related technologies such as
genomics, proteomics and imaging system has accelerated the development of
biomarkers. With the complexity of Central Nervous System (CNS), it is considered
that biomarkers will play a vital role in identifying several neurodegenerative
diseases at early stage, provide more accurate diagnosis and better treatment.
The
global market for Central Nervous System biomarkers has been growing rapidly
over the past two decades and is expected to continue further under the
influence of increased governmental support, rapidly increasing aging
population and advancements in supporting technologies such as genomics,
proteomics and imaging technologies. The world is witnessing a rapid growth in
aging population leading to high prevalence of many CNS disorders such as
Parkinson’s, multiple sclerosis and Alzheimer’s disease. The Aging Research
Center, Karoliska Institute, Sweden suggests that approximately 24 million are affected
with Alzheimer’s disease worldwide.
These
diseases incur significant burden on society, to overcome these burdens
governments are supporting private and public laboratories by funding to
continue their development process. United States government has proposed to
spend USD 140.8 billion in the fiscal 2013 to support research and development
program across the country. Geographically, North America represents the
largest market as healthcare infrastructure ismore advanced as compared to
other regions around the globe and it also has a large population base
suffering from CNS diseases. The emerging markets including India, china,
Brazil and Mexico are poised to show substantial growth due to continuously
improving healthcare facilities in these nations.
Hemoglobin
A1c Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/hemoglobin-a1c-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Blood
glucose testing at regular intervals is very crucial for diabetic patients, in
order to keep a track of fluctuating glucose levels in the blood. The crucial
aim of diabetes treatment is to ensure normal levels of blood glucose.
Hemoglobin A1c (Hb A1c) is a lab test that gives an idea about average levels
of blood sugar for a period of around three months. The test results give an
idea about the efficacy of diabetes treatment plans. It provides insights on
the following parameters:
- Success of the designed diabetes treatment plan.
- Accuracy of test results
The
mechanism of test includes linking of hemoglobin to glucose molecules in red
blood cells. With increasing levels of glucose in red blood cells, there is a
high possibility of hemoglobin molecules being glycated or linked with glucose
molecules. It is recommended to perform the test atleast twice in a year. A1c
levels are reported in terms of percentages. Presently, American Association of
Clinical Endocrinologists recommends around 6.5% A1c to be normal concentration
and American Diabetes Association recommends less than 7.0% A1c in the blood
cells.
The
market for hemoglobin A1c testing is witnessing a consistent growth trend
majorly due to increasing incidence of diabetes mellitus across the globe.
According to the data enumerated by WHO, there are around 347 million diabetic
patients worldwide and diabetes will be seventh leading cause of death by 2030.
Currently, with the approval of U.S. FDA for these tests or assays for
diagnosing diabetes by healthcare professionals, the demand and acceptance of
HbA1c tests will further increase.
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are
specially designed to save time and money for our clients. We are a one stop
solution for all your research needs, our main offerings are syndicated
research reports, custom research, subscription access and consulting services.
We serve all sizes and types of companies spanning across various industries.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
– Canada Toll Free: 866-997-4948
No comments:
Post a Comment